|
P2-121 P-T03C-2859
Biomaterials for theranostics
-
Drug delivery
A preparing method of biodegradable polyester nanoparticles for loading a broad range of chemical drugs
Naehak Park
|
|
P2-122 P-T03C-2858
Biomaterials for theranostics
-
Drug delivery
Anti-cancer polymeric nanomedicines for inhibiting choline metabolism
Naehak Park
|
|
P2-123 O-T03C-0556
Biomaterials for theranostics
-
Drug delivery
AI-based Self-Driving Microfluidic Platform for Fast Optimization in the Manufacturing of Drug-loaded Nanoparticles
Amirreza Mottafegh
|
|
P2-124 P-T03C-3059
Biomaterials for theranostics
-
Drug delivery
Effect of ophthalmic hydrogel and carbomer on the cell viability of mesenchymal stem cells through an intravitreal injection
Hyunhee Helen SEO
|
|
P2-125 P-T03A-4256
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Amplifying glioblastoma immunotherapy: T Cell shielding through NO/ROS scavenging nanoparticles potentiates anti-PD-1
Jihye Lee
|
|
P2-126 P-T03A-4249
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Switchable antibody production and delivering nanoparticles for anti-cancer immunotherapy
Mihyeon Park
|
|
P2-127 P-T03G-4248
Biomaterials for theranostics
-
Nano-biomaterials
Nitric Oxide-scavenging Lubricant Nanoparticles for Advanced Osteoarthritis Therapy
Yunyoung Nah
|
|
P2-128 P-T03C-3360
Biomaterials for theranostics
-
Drug delivery
Evaluation of in-vitro antibiotic release from bioactive glass-based drug delivery device
SeungHyo Go
|
|
P2-129 P-T03C-1491
Biomaterials for theranostics
-
Drug delivery
Comparison and Evaluation of Commercial Transfection Agents as an mRNA Vaccine Delivery Carrier
Jungho Kim
|
|
P2-130 P-T03C-3289
Biomaterials for theranostics
-
Drug delivery
Intravitreal injectable hydrogel rods with highly sustained protein drug delivery to the retina
Dong Hwan OH
|
|
P2-131 P-T03C-3453
Biomaterials for theranostics
-
Drug delivery
Modified SIRPα-Drug Conjugates for CD47-Targeted Cancer Therapy
Seungmi Hue
|
|
P2-132 E-T03C-1680
Biomaterials for theranostics
-
Drug delivery
Cation-free zwitterionic polymers as mRNA delivery career
Akihisa Otaka
|
|
P2-133 O-T03C-0014
Biomaterials for theranostics
-
Drug delivery
Pre-clinical evaluation of miR-145 micelles for atherosclerosis therapy
Eunji Chung
|
|
P2-134 O-T03C-0342
Biomaterials for theranostics
-
Drug delivery
Hepatic delivery of anti-fibrosis drug using hyaluronic acid-coated polymeric micelles
Yuichi Ohya
|
|
P2-135 O-T03C-0356
Biomaterials for theranostics
-
Drug delivery
Consideration of the endothelial glycocalyx in the design of drug delivery systems
Megan Lord
|
|
P2-136 O-T03C-0551
Biomaterials for theranostics
-
Drug delivery
Osmosis-driven delayed pulse release from bioresorbable capsules for vaccine booster delivery
Ferry Melchels
|
|
P2-137 O-T03C-0240
Biomaterials for theranostics
-
Drug delivery
Applicarions of anionic-terminal Phe-modifed dendrimers to delivery into lymph node-resident T cells
Chie Kojima
|
|
P2-138 O-T03C-0324
Biomaterials for theranostics
-
Drug delivery
Glucose-Responsive Biomaterials Design for Improved Diabetes Management
Matthew Webber
|
|
P2-139 E-T03C-0923
Biomaterials for theranostics
-
Drug delivery
Subcutaneous temperature-triggered drug delivery for islet transplantation
Larry Unsworth
|
|
P2-140 O-T03C-0745
Biomaterials for theranostics
-
Drug delivery
Development of hotmelt extruded poly(ɛ-caprolactone) (pcl) matrices for an oral ultra-long-lasting delivery of galantamine for alzheimer’s disease therapy
EDVANI MUNIZ
|
|
P2-141 P-T03C-2145
Biomaterials for theranostics
-
Drug delivery
Nanoparticle Distributed Intravenous Enzyme Replacement Therapy (NanoDIVERT) across the Blood-Brain Barrier
Jessica Larsen
|
|
P2-142 E-T03C-1992
Biomaterials for theranostics
-
Drug delivery
Chitosan-Caffeic acid bactericidal coating for PDMS surfaces: A sustained Moxifloxacin release and prolonged coating adhesion
Pascale Chevallier
|
|
P2-143 P-T03C-3532
Biomaterials for theranostics
-
Drug delivery
Imiquimod microneedles for treating warts: a proof of concept study
Min-Hua Chen
|
|
P2-144 E-T03C-2369
Biomaterials for theranostics
-
Drug delivery
Hydrophobic and hydrophilic modifications of zein: effect on nanoparticle formation and its applications towards intracellular drug delivery
Rekha Ramesan
|
|
P2-145 P-T03E-1136
Biomaterials for theranostics
-
Gene therapy
Iron Oxide Nanorods Delivered miRNA34a for Immunotherapy in Cancer Cells
Li-Fang Wang
|
|
P2-146 E-T03C-1441
Biomaterials for theranostics
-
Drug delivery
Protein Absorption Affects Bioactivity of Fructose-based Nanoparticles
Mingxia Lu
|
|
P2-147 E-T03C-1850
Biomaterials for theranostics
-
Drug delivery
Photocatalytic microneedle reactor for transdermal delivery of carbon monoxide to enhance cisplatin chemotherapy
Youxiang Wang
|
|
P2-148 P-T03C-3791
Biomaterials for theranostics
-
Drug delivery
Engineered hierarchical microdevices enable pre-programmed controlled release for postsurgical and unresectable cancer treatment
Hongli Mao
|
|
P2-149 P-T03D-3295
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Investigating extracellular vesicle profiles using in Vitro tendon models with varying matrix microarchitecture
Brittany Taylor
|
|
P2-150 E-T03C-1598
Biomaterials for theranostics
-
Drug delivery
Ultrasmall gold nanoparticles (2 nm) carrying small-interfering RNA (siRNA) for gene silencing
Natalie Wolff
|
Login
